833 filings
Page 2 of 42
8-K
hwpfrxg1c
22 Apr 24
Soligenix Announces Pricing of $4.75 Million Public Offering
4:05pm
424B4
59q qe8d27466f
19 Apr 24
Prospectus supplement with pricing info
4:05pm
EFFECT
y4eiqcfq69
17 Apr 24
Notice of effectiveness
12:15am
8-K
sbxov
3 Apr 24
Randomized Study with 18 Weeks Continuous Treatment Expected to Replicate and Extend Results from the First, Statistically Significant Phase 3 Study
4:05pm
8-K
fza8fj
22 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
EFFECT
s0uvmdhmoz7 47olsol
18 Dec 23
Notice of effectiveness
12:15am
8-K
hr7dxo6 6xs0zrtel0
15 Dec 23
Submission of Matters to a Vote of Security Holders
4:03pm
CORRESP
0ql0sxl4
14 Dec 23
Correspondence with SEC
12:00am
CORRESP
82dpdqwc2 xdlovv
6 Dec 23
Correspondence with SEC
12:00am
CORRESP
3ytptu
30 Nov 23
Correspondence with SEC
12:00am
8-K
8uo00z2ydip lxceh
17 Nov 23
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
4:05pm
8-K
sqe6mc
20 Oct 23
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
4:05pm